Clinton G M, Rougeot C, Derancourt J, Roger P, Defrenne A, Godyna S, Argraves W S, Rochefort H
Unit Hormones and Cancer, Unité 148, Institut National de la Santé et de la Recherche Médicale, Faculty of Medicine, Montpellier, France.
Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):316-20. doi: 10.1073/pnas.93.1.316.
Ovarian cancers have a high ability to invade the peritoneal cavity and some are stimulated by estrogens. In an attempt to understand the mode of action of estrogens on these cancer cells and to develop new markers, we have characterized estrogen-regulated proteins. This study was aimed at identifying a protein secreted by ovarian cancer cells whose level was increased by estradiol [Galtier-Dereure, F., Capony, F., Maudelonde, T. & Rochefort, H. (1992) J. Clin. Endocrinol. Metab. 75, 1497-1502]. By using microprotein sequencing, the 110-kDa protein was identified as fibulin-1, a protein of the extracellular matrix that binds to fibronectin, laminin, and nidogen. The amount of immunoprecipitated fibulin-1 secreted into the medium and present in the cell extract was increased up to 10-fold by estradiol in three estrogen-responsive ovarian cancer cell lines. By immunohistochemistry fibulin-1 was located in the stroma of several ovarian cancers and cysts. The findings highlight a potential role for fibulin-1 in the spread of ovarian cancer in the peritoneal cavity and/or in distal metastases.
卵巢癌具有很高的侵袭腹膜腔的能力,并且有些卵巢癌受雌激素刺激。为了了解雌激素对这些癌细胞的作用方式并开发新的标志物,我们对雌激素调节蛋白进行了表征。本研究旨在鉴定一种由卵巢癌细胞分泌的、其水平会被雌二醇升高的蛋白质[Galtier-Dereure, F., Capony, F., Maudelonde, T. & Rochefort, H. (1992) J. Clin. Endocrinol. Metab. 75, 1497 - 1502]。通过使用微量蛋白质测序,这种110 kDa的蛋白质被鉴定为纤连蛋白-1,它是一种细胞外基质蛋白,可与纤连蛋白、层粘连蛋白和巢蛋白结合。在三种雌激素反应性卵巢癌细胞系中,分泌到培养基中并存在于细胞提取物中的免疫沉淀纤连蛋白-1的量被雌二醇增加了高达10倍。通过免疫组织化学方法,纤连蛋白-1定位于几种卵巢癌和囊肿的基质中。这些发现突出了纤连蛋白-1在卵巢癌在腹膜腔扩散和/或远处转移中的潜在作用。